Patents by Inventor David Mark Milne-Robertson

David Mark Milne-Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAMETE-SECRETED GROWTH FACTORS
    Publication number: 20200041523
    Abstract: The present invention relates to diagnostic markers of fertility, reproductive dysfunction and infertility management. In particular, the invention relates a method for predicting the fertility potential of a subject, the method comprising determining the level of one or more of GDF9, BMP15 and/or cumulin in the subject.
    Type: Application
    Filed: February 1, 2018
    Publication date: February 6, 2020
    Inventors: Robert Bruce GILCHRIST, Karen CHAN, William Leigh LEDGER, David Mark MILNE-ROBERTSON, Angelique Helena RIEPSAMEN
  • Peptides for development of diagnostic and therapeutic agents and methods of using same
    Patent number: 8399202
    Abstract: Novel immuno-interactive fragments of the ?C portion of a mammalian inhibin ? subunit, together with their variants and derivatives, produce antigen-binding molecules that are interactive with the ?C portion, and which are chemically well defined and which can be produced in commercially significant quantities. The antigen-binding molecules of the invention can be used for the detection of a mammalian inhibin and for the treatment and/or prevention of conditions associated with aberrant levels of a mammalian inhibin.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: March 19, 2013
    Assignee: Prince Henry's Institute of Medical Research
    Inventors: David Mark Milne-Robertson, Peter Gordon Stanton, Nicholas Francis Cahir
  • Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
    Publication number: 20090252735
    Abstract: Novel immuno-interactive fragments of the ?C portion of a mammalian inhibin ? subunit, together with their variants and derivatives, produce antigen-binding molecules that are interactive with the ?C portion, and which are chemically well defined and which can be produced in commercially significant quantities. The antigen-binding molecules of the invention can be used for the detection of a mammalian inhibin and for the treatment and/or prevention of conditions associated with aberrant levels of a mammalian inhibin.
    Type: Application
    Filed: March 30, 2009
    Publication date: October 8, 2009
    Applicant: PRINCE HENRY'S INSTITUTE OF MEDICAL RESEARCH
    Inventors: David Mark MILNE-ROBERTSON, Peter Gordon STANTON, Nicholas Francis CAHIR
  • Immuno-interactive fragments of the alpha-C subunit of inhibin
    Patent number: 7511123
    Abstract: Novels immuno-interactive fragments of the (alpha)C portion of a mammalian inhibin alpha subunit are disclosed, together with their variants and derivatives for producing antigen-binding molecules that are interactive with said (alpha)C portion, which are chemically well defined and which can be produced in commercially significant quantities. The antigen-binding molecules of the invention can be used for the detection of a mammalian inhibin and for the treatment and/or prevention of conditions associated with aberrant levels of a mammalian inhibin.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: March 31, 2009
    Assignee: Prince Henry's Institute of Medical Research
    Inventors: David Mark Milne-Robertson, Peter Gordon Stanton, Nicholas Francis Cahir
  • Polynucleotides that encode bovine inhibin
    Patent number: 6613891
    Abstract: Recombinant nucleic acid molecules encoding 58 kD, 43 kD, 31 kD, 20 kD and 15 kD bovine inhibin and bovine inhibin subunits are disclosed. Vectors, host cells comprising recombinant nucleic acid molecules encoding bovine inhibin and bovine inhibin subunits are disclosed. In addition, methods for producing bovine inhibin and bovine inhibin subunits are disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 2, 2003
    Assignee: Inhibin Pty. Limited
    Inventors: Robert Gregory Forage, Andrew George Stewart, David Mark Milne-Robertson, David Moritz de Kretser, John Kerr Findlay
  • Immuno-interactive fragments of the alpha-C subunit of inhibin
    Publication number: 20030162229
    Abstract: Novels immuno-interactive fragments of the (alpha)C portion of a mammalian inhibin alpha subunit are disclosed, together with their variants and derivatives for producing antigen-binding molecules that are interactive with said (alpha)C portion, which are chemically well defined and which can be produced in commercially significant quantities. The antigen-binding molecules of the invention can be used for the detection of a mammalian inhibin and for the treatment and/or prevention of conditions associated with aberrant levels of a mammalian inhibin.
    Type: Application
    Filed: April 18, 2002
    Publication date: August 28, 2003
    Applicant: Prince Henry's Institute of Medical Research
    Inventors: David Mark Milne-Robertson, Peter Gordon Stanton, Nicholas Francis Cahir